EAGLE CRAIG
Transaction: 07/01/2026
OTHER
Change
0
Price
Not reported
Filing
07/23/2026
Type
OTHER
OS Therapies Incorporated
OSTX • Biotechnology
$1.27
▲ +0.01 (+0.79%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$65.57M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak liquidity · 0.03Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.27
Change0.79%
Market Cap$65.57M
52W Range1.15 - 2.57
Beta-0.73
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.03
Quick Ratio0.03
Volume225.03K
Price$1.27
Change0.79%
Market Cap$65.57M
52W Range1.15 - 2.57
Beta-0.73
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.03
Quick Ratio0.03
Volume225.03K
Avg Volume682.35K
EPS Surprise-0.10
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Manageable debt level · 0Weak liquidity · 0.03Weak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Romness Paul A.
Transaction: 12/05/2024
BUY
Change
+500,000
Price
$1.86
Filing
05/15/2026
Type
BUY
Galzahr Karim
Transaction: 01/22/2026
BUY
Change
+50,000
Price
$1.34
Filing
02/13/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| EAGLE CRAIG | OTHER | 0 | Not reported | 07/01/2026 | 07/23/2026 |
| Romness Paul A. | BUY | +500,000 | $1.86 | 12/05/2024 | 05/15/2026 |
| Galzahr Karim | BUY | +50,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| Jarry Olivier Roger | BUY | +50,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| Romness Paul A. | BUY | +1,000,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| PETIT ROBERT | BUY | +100,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| Acevedo Christopher P. | BUY | +100,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| Ciccio John | BUY | +50,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| Search Theodore F. | BUY | +50,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| McKean-Dieser Avril Suzette | BUY | +50,000 | $1.34 | 01/22/2026 | 02/13/2026 |
| Romness Paul A. | BUY | +1,000,000 | $1.80 | 10/21/2025 | 02/13/2026 |
| McKean-Dieser Avril Suzette | BUY | +140,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| Acevedo Christopher P. | BUY | +200,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| Ciccio John | BUY | +140,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| Galzahr Karim | BUY | +140,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| Jarry Olivier Roger | BUY | +140,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| Romness Paul A. | BUY | +1,950,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| PETIT ROBERT | BUY | +500,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| Search Theodore F. | BUY | +140,000 | $1.80 | 10/21/2025 | 12/19/2025 |
| Auerbach Shalom | OTHER | 0 | Not reported | 05/09/2025 | 05/09/2025 |